quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:08·1488d
SECFiling
BioDelivery Sciences International Inc. logo

SEC Form EFFECT filed by BioDelivery Sciences International Inc.

BDSI· BioDelivery Sciences International Inc.
Health Care
Original source

Companies

  • BDSI
    BioDelivery Sciences International Inc.
    Health Care

Recent analyst ratings

  • Feb 15UpdatePiper Sandler$5.60
  • Jan 21UpdateHC Wainwright & Co.$4.50
  • Nov 4UpdateHC Wainwright & Co.$4.50
  • Aug 5UpdateHC Wainwright & Co.$6.00

Related

  • 13D/G1168d
    SEC Form SC 13G/A filed by BioDelivery Sciences International Inc. (Amendment)
  • PR1277d
    Genenta Provides First Half 2022 Business Update and Financial Results
  • PR1457d
    Genenta Announces Nomination of Mark A. Sirgo as Chair
  • SEC1483d
    SEC Form 15-12B filed by BioDelivery Sciences International Inc.
  • NEWS1487d
    Overview Of Value Stocks In The Healthcare Sector
  • SEC1492d
    SEC Form S-8 POS filed by BioDelivery Sciences International Inc.
  • SEC1492d
    SEC Form POS AM filed by BioDelivery Sciences International Inc.
  • INSIDER1493d
    SEC Form 4: Watson W. Mark disposed of 90,663 shares, closing all direct ownership in the company to satisfy tax liability
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022